Icon

NAMENDA XR (nda022525)- (7MG,14MG,21MG,28MG)

MEMANTINE HYDROCHLORIDE ABBVIE
7MG,14MG,21MG,28MG
Yes No
2029-Sep-24 Expired
None None
None No
NAMENDA XR is a N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.
9 2 8
Total Other Developers 8
Drugs with Suitability No
7MG ** ** Down 5 -
14MG ** ** Down - 5
21MG ** ** Down - 5
28MG ** ** Down - 5
NDA Sales Available Total Generic Sales Available
Yes 7
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***
****** ***** *** ***** ******* *********** ****-*, **** **. *-* *** *-*-*, ******* ******** **** ***** **, ****. ****, ******* ****, ****. ****, *********, ****** ******* ******, ***** (***) ***
****** ******* ********* ******* ********* **** ***** ****** ***** *********** **. ***, ******* ****, *******, ***** ******, ***** (***) ***
****** ********* ****** *** *** ********** ******* *********** ****-**, **** **.**, *****, *.*.***, ******** *******, ********* ******, ******** ********, ********, ****** ******* ******, ***** (***) ***
****** ****** ** ***** ** ****** ** ************** **., ***. *********** **** ******** **** ****, ******, ****** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.